TICLOPIDINA MYLAN GENERICS 250 mg compresse rivestite clinical trials

Tailored antiplatelet secondary prevention in non-cardioembolic ischemic stroke: a phase IV gender-stratified randomized controlled trial (TAILOR trial)

This study is looking at different common medicines to prevent another stroke or heart attack in people who have already had a certain type of stroke. It compares how well these medicines work and if there are differences between men and women.